Utility of delayed reading of intradermal test in carboplatin-induced drug hypersensitivity
| Medienart: |
Artikel |
|---|
| Erscheinungsjahr: |
2015 |
|---|---|
| Erschienen: |
2015 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:114 |
|---|---|
| Enthalten in: |
Annals of allergy, asthma, & immunology - 114(2015), 6, Seite 534 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
D'Amelio, C M [VerfasserIn] |
|---|
| Links: |
|---|
| Förderinstitution / Projekttitel: |
|
|---|
| PPN (Katalog-ID): |
OLC1963895614 |
|---|
| LEADER | 01000caa a2200265 4500 | ||
|---|---|---|---|
| 001 | OLC1963895614 | ||
| 003 | DE-627 | ||
| 005 | 20230714161756.0 | ||
| 007 | tu | ||
| 008 | 160206s2015 xx ||||| 00| ||eng c | ||
| 028 | 5 | 2 | |a PQ20160617 |
| 035 | |a (DE-627)OLC1963895614 | ||
| 035 | |a (DE-599)GBVOLC1963895614 | ||
| 035 | |a (PRQ)p835-16c4bf3dcfbc41f464b276c4d8b68eacf5b33fb594d26da2fb3235267a08cbc40 | ||
| 035 | |a (KEY)0023234320150000114000600534utilityofdelayedreadingofintradermaltestincarbopla | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 082 | 0 | 4 | |a 610 |q DNB |
| 100 | 1 | |a D'Amelio, C M |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Utility of delayed reading of intradermal test in carboplatin-induced drug hypersensitivity |
| 264 | 1 | |c 2015 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ohne Hilfsmittel zu benutzen |b n |2 rdamedia | ||
| 338 | |a Band |b nc |2 rdacarrier | ||
| 650 | 4 | |a Carboplatin - therapeutic use | |
| 650 | 4 | |a Antibodies, Monoclonal, Humanized - therapeutic use | |
| 650 | 4 | |a Drug Hypersensitivity - diagnosis | |
| 650 | 4 | |a Hypersensitivity, Delayed - etiology | |
| 650 | 4 | |a Carboplatin - adverse effects | |
| 650 | 4 | |a Paclitaxel - therapeutic use | |
| 650 | 4 | |a Peritoneal Neoplasms - drug therapy | |
| 650 | 4 | |a Antineoplastic Combined Chemotherapy Protocols - therapeutic use | |
| 650 | 4 | |a Skin Tests - methods | |
| 650 | 4 | |a Ovarian Neoplasms - drug therapy | |
| 650 | 4 | |a Hypersensitivity, Delayed - diagnosis | |
| 650 | 4 | |a Antineoplastic Agents - adverse effects | |
| 650 | 4 | |a Drug Hypersensitivity - etiology | |
| 650 | 4 | |a Antineoplastic Agents - therapeutic use | |
| 700 | 1 | |a Aramendía, J M |4 oth | |
| 700 | 1 | |a Yuste, J R |4 oth | |
| 700 | 1 | |a Fusco, J P |4 oth | |
| 700 | 1 | |a Gastaminza, G |4 oth | |
| 700 | 1 | |a Goikoetxea, M J |4 oth | |
| 773 | 0 | 8 | |i Enthalten in |t Annals of allergy, asthma, & immunology |d New York, NY : Elsevier, 1995 |g 114(2015), 6, Seite 534 |w (DE-627)183944348 |w (DE-600)1228189-X |w (DE-576)045316767 |x 1081-1206 |7 nnns |
| 773 | 1 | 8 | |g volume:114 |g year:2015 |g number:6 |g pages:534 |
| 856 | 4 | 2 | |u http://www.ncbi.nlm.nih.gov/pubmed/26021896 |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a SYSFLAG_A | ||
| 912 | |a GBV_OLC | ||
| 912 | |a SSG-OLC-PHA | ||
| 912 | |a SSG-OLC-DE-84 | ||
| 912 | |a GBV_ILN_2008 | ||
| 912 | |a GBV_ILN_4012 | ||
| 912 | |a GBV_ILN_4112 | ||
| 912 | |a GBV_ILN_4219 | ||
| 912 | |a GBV_ILN_4305 | ||
| 951 | |a AR | ||
| 952 | |d 114 |j 2015 |e 6 |h 534 | ||